Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2025-12-24 @ 4:50 PM
NCT ID:
NCT02156050
Eligibility Criteria:
Inclusion Criteria:
* Newborn infants ≥ 38 gestation weeks without or with risk factors of severe icterus (G6PD or pyruvate-kinase deficiency, red blood cells membrane defects, hemoglobinopathies, cephalohematoma or significant bruising, decreased breastfeeding)
* newborn at 35 and 38 gestation weeks without risk factor of severe icterus (qs)
* hyperbilirubinemia to deal according to the curves of indication of phototherapy of the APP on 2004
* no opposition of parents
Exclusion Criteria:
* opposition of parents
* newborn infants less than 33 weeks
* newborn infants at 35 or more weeks of gestation with risk factors of severe icterus
* Jaundice in first 12 hours
* Hyperbilirubinemia \> 340 µmol/L whatever is the age
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Weeks
Maximum Age:
42 Weeks
Study:
NCT02156050
Study Brief:
Protocol Section:
NCT02156050